Smith & Nephew plc (NYSE:SNN – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $29.50, but opened at $28.27. Smith & Nephew shares last traded at $28.20, with a volume of 372,680 shares traded.
Analyst Ratings Changes
Several research analysts recently commented on the company. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Deutsche Bank Aktiengesellschaft assumed coverage on Smith & Nephew in a research report on Wednesday, July 24th. They issued a “buy” rating on the stock. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy”.
View Our Latest Analysis on SNN
Smith & Nephew Trading Down 3.8 %
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. Park Avenue Securities LLC lifted its holdings in Smith & Nephew by 12.1% in the first quarter. Park Avenue Securities LLC now owns 17,738 shares of the medical equipment provider’s stock worth $450,000 after purchasing an additional 1,911 shares during the period. BKM Wealth Management LLC lifted its stake in shares of Smith & Nephew by 17.8% in the 1st quarter. BKM Wealth Management LLC now owns 18,240 shares of the medical equipment provider’s stock worth $463,000 after acquiring an additional 2,757 shares during the period. Legacy Wealth Asset Management LLC increased its stake in shares of Smith & Nephew by 6.0% during the first quarter. Legacy Wealth Asset Management LLC now owns 16,022 shares of the medical equipment provider’s stock valued at $406,000 after acquiring an additional 903 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Smith & Nephew by 13.8% during the first quarter. Janney Montgomery Scott LLC now owns 9,611 shares of the medical equipment provider’s stock valued at $244,000 after acquiring an additional 1,165 shares during the period. Finally, Inspire Advisors LLC lifted its position in Smith & Nephew by 4.7% in the first quarter. Inspire Advisors LLC now owns 21,647 shares of the medical equipment provider’s stock worth $549,000 after purchasing an additional 970 shares during the period. Institutional investors own 25.64% of the company’s stock.
About Smith & Nephew
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Further Reading
- Five stocks we like better than Smith & Nephew
- What does consumer price index measure?
- Texas Roadhouse Stock Steering for New Highs This Year
- How to Calculate Inflation Rate
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.